Novel microsatellite loci were identified in the T. truncatus genome using Illumina 454 sequencing of the genome following Lance et al. (2013) at the Savannah River Ecology Laboratory (SREL). Five tetranucleotide loci were screened by the SREL for amplification and polymorphism and determined to be suitable candidates for genotyping. Primers were designed for an additional 41 loci identified by the Illumina 454 sequencing (Ttr50-Ttr61 and Ttr70-Ttr100) at the NMFS SEFSC Marine Mammal Molecular Genetics laboratory. These loci were first screened via gel electrophoresis as follows: each locus was amplified alone with 20mM Tris-HCl (pH 8.4), 50mM KCl, 1.5mM MgCl 2 , 0.4µM of each primer, 0.15mM dNTPs, 0.6U of Taq polymerase (Invitrogen), and 25ng of DNA using the following PCR profile, 94°C for 30 s followed by 33 cycles of 94°C for 30 s, 54°C for 30 s, 72°C for 30 s and a 72°C final extension for 10 min. PCR products were viewed by electrophoresis on a 4.7% MetaPhor Agarose (Lonza) gel and analyzed for amplification, variability and base pair size. Seventeen loci (Ttr50, Ttr73-Ttr75, Ttr77, Ttr79-Ttr82, Ttr88, Ttr92-Ttr97 and Ttr99) were determined to have poor or no amplification, non-specific amplification, low or no variability, or unfavorable base pair size and therefore not included in further optimizations. The forward primer of each locus (n=29) that was determined to be of good quality by MetaPhor gel analysis or the SREL screening was fluorescently dye labeled. These microsatellite loci were then amplified for at least seven individuals in multiplexes of 6-9 loci using the Type-it® Microsatellite PCR Kit (Qiagen). PCR amplification was performed in 10 uL reactions of 1x Type-it Multiplex PCR Master Mix, 0.1µM of each primer and 10 ng of DNA. PCR conditions consisted of an initial heat activation step at 95°C for 5 min followed by 25-28 cycles of 95°C for 30 s, 54-60°C for 90 s, 72°C for 30 s and a 60°C final extension for 30 min.
Twenty microsatellite loci previously developed in T. truncatus and other cetacean species, were also tested. PCR products from at least 4 individuals were amplified alone or in multiplexes of 2-4 loci with 20mM Tris-HCl (pH 8.4), 50mM KCl, 1.5-3.0 mM MgCl 2 , 0.075-0.3µM primers, 0.15mM dNTPs, 0.6U of Taq polymerase (Invitrogen), and 25ng of DNA using the following PCR profile, 94°C for 30 s followed by 26-35 cycles of 94°C for 30 s, 45-55°C for 30 s, 72°C for 30 s and a 72°C final extension for 10 min. Products were run on an ABI 310 or ABI 3130 Genetic Analyzer with Genescan Tamra-500 or Genescan Liz-500 size standard, respectively, and viewed using Genotyper 2.5 or GeneMapper v5 (Applied Biosystems). After analyzing the resulting genotypes, 10 loci (D28 Shinohara et al. (1997) ; Dde72 Coughlan et al. (2006) ; DlrFCB4 and DlrFCB8 Buchanan et al. (1996) ; GM415/416 and GM417/418 Amos et al. (1993) ; KWM2a Hoelzel et al. (1998) ; Ppho110 (Rosel et al. 1999 ); SW10 and SW13 Richard et al. 1996) ) were removed from further analysis due to low or no variability, bad peak shape, inconsistent allele repeat sizes, or non-specific amplification, leaving 10 loci for further testing.
The remaining 29 loci were amplified in multiplexes using the Type-it® Microsatellite PCR Kit (Qiagen) as described above for at least 3 populations of bottlenose dolphins with 29 or more samples in each population. We tested each locus for departure from Hardy-Weinberg equilibrium (HWE) using the Fisher exact test (Guo & Thompson 1992) and linkage disequilibrium was assessed in GENEPOP v4.2 (Raymond & Rousset 1995 , Rousset 2008 ) using 10000 dememorizations, 1000 batches and 10000 iterations per batch. Each microsatellite locus was evaluated for genotyping errors due to null alleles, allelic dropout and/or incorrect scoring of stutter peaks using Microchecker v2.2.3 (Van Oosterhout et al. 2004) . One locus (DlrFCB5) was excluded from further analysis due to bad peak shape. DLrFCB17 and five of the novel SREL loci (Ttr11(tetra), Ttr20, Ttr51, Ttr57, Ttr98) were determined to have significant departure from HWE and/or the presence of null alleles and therefore removed from analyses. Thus, out of the 46 novel SREL loci and 20 pre-existing loci screened, 22 loci (14 novel and 8 pre-existing) passed all screening tests and were used to genotype all samples. Supplementary Table 2 provides PCR conditions for the newly developed/optimized loci. 
